Bruker

Bruker

High-performance scientific instruments and high-value analytical and diagnostic solutions.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*
N/A

N/A

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth22 %5 %17 %14 %4 %4 %6 %
EBITDA0000000000000000000000000000
% EBITDA margin21 %22 %20 %18 %18 %19 %20 %
Profit0000000000000000000000000000
% profit margin11 %12 %14 %3 %7 %9 %11 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue9 %9 %10 %11 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Bruker

Edit
Biognosys
ACQUISITION by Bruker Jan 2023
Jordan Valley Semiconductors
ACQUISITION by Bruker Oct 2015
Inscopix
ACQUISITION by Bruker Nov 2022
Prairie Technologies
ACQUISITION by Bruker Sep 2013
NanoString Technologies
ACQUISITION by Bruker Apr 2024
Arxspan
ACQUISITION by Bruker Mar 2019
Biocrates Life Sciences
ACQUISITION by Bruker Jun 2025
Phase Focus
ACQUISITION by Bruker Dec 2023
Molecubes
ACQUISITION by Bruker Nov 2021
View 42 more